Article Text

PDF
Association of plasma cell subsets in the bone marrow and free light chain concentrations in the serum of monoclonal gammopathy patients
  1. Michael John Ayliffe1,
  2. Judith Behrens2,
  3. Simon Stern2,
  4. Nazira Sumar1
  1. 1Department of Immunology, Epsom and St Helier University Hospitals NHS Trust, Carshalton, Surrey, UK
  2. 2Department of Haematology, Epsom and St Helier University Hospitals NHS Trust, Carshalton, Surrey, UK
  1. Correspondence to Michael John Ayliffe, Department of Immunology, St Helier Hospital, Wrythe Lane, Carshalton, Surrey SM5 1AA, UK; michael.ayliffe{at}talktalk.net

Abstract

This study investigated bone marrow plasma cell subsets and monoclonal free light chain concentrations in blood of monoclonal gammopathy patients. 54 bone marrow samples were stained by double immunofluorescence to enumerate cellular subsets making either intact monoclonal immunoglobulin or free light chains only. Blood taken at the same time was assayed for free light chains by an automated immunoassay. Patients were assigned to three cellular population categories: single intact monoclonal immunoglobulin (59%), dual monoclonal immunoglobulin and free light chain only (31%), or single free light chain only (9%). The median affected free light chain concentration of each group was 75 mg/l, 903 mg/l and 3320 mg/l, respectively, but with substantial overlap. In myeloma patients the difference in serum free light chain concentrations between patients with free light chain only marrow cells and those without was statistically significant. Serum free light chain levels >600 mg/l result mostly from marrow cells restricted to free light chain production.

  • Antibodies
  • amyloid
  • immunofluorescence
  • immunoglobulin
  • myeloma

Statistics from Altmetric.com

Footnotes

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval London–Surrey Borders Research Ethics Committee approved the study.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.